The stereoisomers of 17α-[123I]iodovinyloestradiol and its 11β-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats

European Journal of Nuclear Medicine

Volumn 23, Issue 3, 1996, Pages 295-307

  Rijks, Leonie J M ^a   Boer, Gerard J ^b   Endert, Erik ^a   De Bruin, Kora ^a   Van Den Bos, Jan C ^c   Van Doremalen, Peter A P M ^c   Schoonen, Willem G E J ^d   Janssen, Anton G M ^c   Van Royen, Eric A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^d NV ORGANON   (Netherlands)

Author keywords

17 123i iodovinyloestradiol derivatives; Breast tumour imaging; Immature rat; Oestrogen receptor radioligand; Single photon emission tomography

Indexed keywords

17ALPHA ESTRADIOL; 17ALPHA IODOVINYLESTRADIOL I 123; DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; IODINE 123; MOXESTROL; RADIOLIGAND; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG; 17 ALPHA IODOVINYL 11 BETA METHOXYESTRADIOL; 17 ALPHA IODOVINYLESTRADIOL; 17 ALPHA-IODOVINYL-11 BETA-METHOXYESTRADIOL; 17 ALPHA-IODOVINYLESTRADIOL; DRUG DERIVATIVE; ESTRADIOL;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BREAST CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; FEMALE; HUMAN; HUMAN CELL; HYPOPHYSIS; METABOLISM; NONHUMAN; OVARY; RECEPTOR BINDING; STEREOISOMERISM; TARGET ORGAN; TEMPERATURE; UTERUS; ANIMAL; BREAST TUMOR; EXPERIMENTAL NEOPLASM; KINETICS; RADIOASSAY; RAT;

ANIMALS; BREAST NEOPLASMS; ESTRADIOL; FEMALE; HUMANS; KINETICS; MAMMARY NEOPLASMS, ANIMAL; RADIOLIGAND ASSAY; RATS; RECEPTORS, ESTROGEN; STEREOISOMERISM;

EID: 0029664612     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00837628     Document Type: Article

References (64)

1. De Waard F. Epidemiology of breast cancer; a review. Eur J Cancer Clin Oncol 1983; 19: 1671-1676.
2. Van Bon-Martens MJH, Verbeek ALM, Peeters PHM, Luning P, Werre JM. Een overzicht van de epidemiologie van borstkanker in Nederland. Ned Tijdschr Geneeskd 1990; 134: 287-291.
3. Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken SC, Warren R. Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. Eur J Cancer 1980; 16: 323-331.
4. McGuire WL, Horwitz KB, Pearson OH, Segaloff A. Current status of estrogen and progesterone receptors in breast cancer. Cancer 1977; 39: 2934-2947.
5. Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1.015 breast cancer patients. J Clin Oncol 1987; 5: 55-61.
6. Donegan WL. Prognostic factors; stage and receptor status in breast cancer. Cancer 1992; 70: 1755-1764.
7. Van Netten JP, Armstrong JB, Carlyle SS, Goodchild NL, Thornton IG, Brigden ML, Coy P, Fletcher C. Estrogen receptor distribution in the peripheral, intermediate, and central regions of breast cancers. Eur J Cancer Clin Oncol 1988; 24: 1885-1889.
8. Holdaway IM, Bowditch JV. Variation in receptor status between primary and metastatic breast cancer. Cancer 1983; 52: 479-485.
9. Mobbs BG, Fisch EB, Pritchard KI, Oldfield G, Hanna WH. Estrogen and progesterone receptor content of primary and secondary breast carcinoma: influence of time and treatment. Eur J Cancer Clin Oncol 1987; 23: 819-826.
10. Eckelman WC, Reba RC. Labeled estrogens and analogues. In: Spencer RP, ed. Radiopharmaceuticals: structure-activity relationships. New York: Grune and Stratton; 1981: 449-458.
11. Katzenellenbogen JA, Carlson KE, Heiman DF, Lloyd JE. Receptor binding as a basis for radiopharmaceutical design. In: Spencer RP, ed. Radiopharmaceuticals: structure-activity relationships. New York: Grune and Stratton; 1981: 23-86.
12. Hochberg RB. Iodine-125-labeled estradiol: a gamma-emitting analog of estradiol that binds to the estrogen receptor. Science 1979; 205: 1138-1140.
13. 125I]iodovinylestradiol: an estrogen-receptor-seeking radiopharmaceutical. J Nucl Med 1982; 23: 431-436.
14. 125]iodovinyl-11β-methoxyestradiol as a highly selective radioligand for tissues containing estrogen receptors: concise communication. J Nucl Med 1984; 25: 998-1002.
15. Katzenellenbogen JA, Carlson KE, Heiman DF, Goswami R. Receptor-binding radiopharmaceuticals for imaging breast tumours: estrogen receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs. J Nucl Med 1980; 21: 550-558.
16. Kiesewetter DO, Kilbourn MR, Landvatter SW, Heiman DF, Katzenellenbogen JA, Welch MJ. Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissues in immature rats. J Nucl Med 1984; 25: 1212-1221.
17. Feenstra A, Nolten GMJ, Vaalburg W, Reiffers S, Woldring MG. Radiotracers binding to estrogen receptors: 1: tissue distribution of 17α-ethynylestradiol and moxestrol in normal and tumor-bearing rats. J Nucl Med 1982; 23: 599-605.
18. Katzenellenbogen JA, Johnson HJR, Myers HN. Photoaffinity labels for estrogen binding proteins of rat uterus. Biochemistry 1973, 12: 4085-4092.
19. 77Br]bromonorhexestrol), two gamma-emitting estrogens that show receptor-mediated uptake by target tissues in vivo. J Med Chem 1982; 25: 1307-1312.
20. 125I]iodo-estradiol with estrogen receptor and other steroid-binding proteins. Proc Natl Acad Sci USA 1980; 77: 328-332.
21. Lippman ME, Do HMT, Hochberg RB. Specific estrogen receptor binding and biological effects of 16α-iodoestradiol on human breast cancer cells. Cancer Res 1981; 41: 3150-3154.
22. 125I]iodoestradiol-17β. J Nucl Med 1982; 23: 420-424.
23. Jagoda EM, Gibson RE, Goodgold H, Ferreira N, Francis BE, Reba RC, Rzeszotarski WJ, Eekelman WC. [I-125] 17α-iodovinyl 11β-methoxyestradiol: in vivo and in vitro properties of a high-affinity estrogen-receptor radiopharmaceutical. J Nucl Med 1984; 25: 472-477.
24. 125I]iodo-11β-methoxy-19-norgregna-1,3,5(10),20-tetraene-3,17- diol (17α-(iodovinyl)estradiol derivatives) as high specific activity potential radiopharmaceticals. J Med Chem 1984; 27: 1287-1291.
25. Mintun MA, Welch MJ, Siegel BA, Mathias CJ, Brodack JW, McGuire AHM, Katzenellenbogen JA. Breast cancer: PET imaging of estrogen receptors. Radiology 1988; 169: 45-48.
26. 18F]fluoro-17β-estradiol uptake in mEtastatic breast carcinoma. J Nucl Med 1991; 32: 1526-1531.
27. 2). Eur J Nucl Med 1990; 16: 430.
28. Schober O, Scheidhauer K, Jackisch C, Schicha H, Smolarz K, Bolle A, Reiners C, Höffken K, Biersack HJ, Briele B, Moser E, Bräutigam P. Breast cancer imaging with radioiodinated oestradiol. Lancet 1990; 335: 1522.
29. 123J-markiertem Östradiol beim Mammakarzinom-Rezeptorszintigraphie. Nucl-Med 1991; 30: 84-99.
30. 125I]iodo)-estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumours. J Nucl Med 1981; 22: 459-464.
31. 131I|iodo-oestradiol and evaluation of its use as a radiotracer for oestrogen receptor positive breast tumours. J Steroid Biochem 1985; 22: 155-160.
32. 77Br]bromo-11β-methoxyestradiol-17β: a gamma-emitting estrogen imaging agent with high uptake and retention by target organs. J Nucl Med 1982; 23: 411-419.
33. 123I]iodoestradiol and its interaction with the estrogen receptor in vivo and in vitro. J Nucl Med 1989; 30: 209-215.
34. 125I]iodo-11-substituted-19-norpregna-1,3,5 (10),20-tetraene-3,17β-diols: the influence of 11-stereochemistry on tissue distribution of radioiodinated estrogens. Nucl Med Biol 1989; 16: 3-9.
35. Quivy J, Delcorde A, Henrot P, Deblaton M, Pirotte R, Verbist A, Frühling J, Zeicher M. New steroidal agent with high selectivity for the radioimaging of tumour tissues containing estrogen receptors. Eur J Nucl Med 1990; 16: 430.
36. 125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17-diols. J Med Chem 1991; 34: 854-860.
37. 125]iodovinyl-11β-ethyl-estradiol. Nucl Med Biol 1993; 20: 351-358.
38. 125I]iodovinylestradiols: effect on receptor binding and receptor-mediated target tissue uptake. J Med Chem 1993; 36: 3061-3072.
39. 2). Part II. Preliminary results in patients with breast carcinoma. Nucl Med Biol 1992; 19: 263-267.
40. 2). Part I. Radiotracer preparation and characterization. Nucl Med Biol 1992; 19: 257-261.
41. Napolitano E, Fiaschi R, Hanson RN. Structure-activity relationships of estrogenic ligands: synthesis and evaluation of (17α, 20E)- and (17α, 20Z)-21-halo-19-norpregna-1,3.5(10). 20-tetraene-3,17β-diols. J Med Chem 1991; 34: 2754-2759.
42. 125I]-11β-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7). Cancer Res 1986; 46: 2386-2389.
43. 125I-iodinated estrogen derivatives in human breast cancer cells (MCF-7). J Steroid Biochem Mol Biol 1993; 44: 105-112.
44. McElvany KD, Carlson KE, Katzenellenbogen JA, Welch MJ. Factors affecting the target site uptake selectivity of estrogen radiopharmaceuticals: serum binding and endogenous estrogens. J Steroid Biochem 1983; 18: 635-641.
45. 125I]iodovinylestradiol derivatives in normal and tumor-bearing adult female rats. Nucl Med Biol 1990; 17: 239-245.
46. 125I]VMEME). Nucl Med Biol 1988; 15: 327-332.
47. Hughes A, Galley SJ, DeSombre ER. Comparison of the distribution of radioiodinated-E-17α-iodovinyl-11β-methoxyestradiol and 2-iodo-1,1-bis(4-hydroxyphenyl)-phenylethylene estrogens in the immature female rat. J Nucl Med 1993; 34: 272-280.
48. Hoyte RM, Rosner W, Johnson IS, Zielinski J, Hochberg RB. Synthesis and evaluation of potential radioligands for the progesterone receptor. J Med Chem 1985; 28: 1695-1699.
49. 125I]iodo-19-norpregna-1,3,5(10),20-tetene-3,17-diol. J Med Chem 1988; 31: 1946-1950.
50. Witsenboer AJ, De Goeij JJM, Reiffers S. Production of iodine-123 via proton irradiation of 99.8% enriched xenon-124. J Lab Comp Radiopharm 1986; 23: 1284-1285.
51. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
52. Munson PJ, Rodbard D, Ligand: a versatile computerized approach for characterization of ligand binding systems. Anal Biochem 1980; 107: 220-239.
53. Feenstra MGP, Snijdewint FGM, Van Galen H, Boer GJ. Widespread alterations in central noradrenaline, dopamine and serotonin systems in the Brattleboro rat not related to the local absence of vasopressin. Neurochem Res 1990; 15: 283-288.
54. Raynaud JP, Bouton M-M, Gallet-Bourquin D, Philibert D, Tournemine C, Azadian-Boulanger G. Comparative study of estrogen action. Mol Pharmacol 1973; 9: 520-533.
55. Pomper MG, VanBrocklin H, Thieme AM, Thomas RD, Kiesewetter DO, Carlson KE, Mathias CJ, Welch MJ, Katzenellenbogen JA. 11β-methoxy-, 11β-ethyl- and 17α-ethynyl-substituted 16α-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity. J Med Chem 1990; 33: 3143-3155.
56. 125I]iodo oestradiols. Biochem Pharmacol 1992; 44: 741-746.
57. Dionne FT, Lesage RL, Dubé JY, Tremblay RR. Estrogen binding proteins in rat skeletal and perineal muscles: in vitro and in vivo studies. J Steroid Biochem 1979; 11: 1073-1080.
58. 3H]-estradiol in rat adipose tissues. Am J Physiol 1981; 240: E43-E46.
59. Salmon J, Coussediere D, Cousty C, Raynaud JP. Pharmacokinetics and metabolism of moxestrol in animals (rat, dog, monkey). J Steroid Biochem 1983; 19: 1223-1234.
60. 18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors. J Med Chem 1993; 36: 1619-1629.
61. 18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors. Life Sci 1993; 53: 811-819.
62. 18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development. Nucl Med Biol 1993; 20: 735-745.
63. Murono EP, Kirdani RY, Sandberg AA. Specific estradiol-17β binding component in adult rat kidney. J Steroid Biochem 1979; 11: 1347-1351.
64. Morgan DD, Grossman CJ. Analysis and properties of the cytosolic estrogen receptor from rat thymus. Endocr Res 1984; 10: 193-207.